Nextremity Solutions, Inc. Announces Letter of Intent to Acquire Lakeland Technology, Inc.

Warsaw, Indiana, February 3, 2020 — Nextremity Solutions, Inc., a strategic commercialization organization with a focus in the extremity market, located in “The Orthopedic Capital of the World,” Warsaw, Ind., today announced it has entered into a  letter of intent to acquire substantially all of the assets of Lakeland Technology, Inc.

Lakeland Technology, Inc., previously known as B&M instruments since 1986, was founded in 2007 and is an ISO 13485 certified contract manufacturer with a focus on quality. Their engineering staff assists with design for manufacturability (DFM) during the design process. Additionally, they specialize in manufacturing implants, instruments, complex assemblies, prototypes, and custom surgical instruments.

Nextremity Solutions, Inc. was founded in 2006 and in 2016 announced their i3® Strategic Solutions strategy that focused their efforts on product development and micro-commercialization of innovative technologies. Nextremity is committed to delivering Revenue Ready® solutions that include effective packaging and delivery systems, creating effective marketing and educational support materials, while providing products with proven sales and clinical efficacy to their industry partners.

Ryan Schlotterback, Chief Technology Officer of Nextremity Solutions said, “Lakeland Technology is an excellent strategic fit for Nextremity Solutions and supports our core business of innovative product development and our micro-commercialization strategy. As we continue to develop Revenue Ready solutions, it’s even more important that we are able to participate in the entire value stream in order to benefit our industry partners.”

“As we evaluated the opportunity, we wanted to ensure that there would be limited disruption in the way we currently operate, who we provide our manufacturing services to, and most importantly our employees. By combining the impressive skills and capabilities of Nextremity Solutions with our strong manufacturing skills we will be able to better serve current customers, and firmly believe that all parties will benefit favorably from this acquisition,” commented Terry Sites, President of Lakeland Technology.

Rod K. Mayer, President & CEO of Nextremity Solutions added, “Our board of directors and our executive management team is excited to take this next strategic step forward in optimizing our ability to deliver comprehensive and innovative solutions to the surgeons, patients, and industry partners that we serve.”

About Lakeland Technology, Inc.

Lakeland Technology, Inc is a privately held contract manufacturer for the medical device industry.  Lakeland offers a wide range of services including Design for Manufacturability, precision machining, finishing, inspection, and packaging.  Lakeland manufactures implants, instruments, prototypes, custom instruments, and is known for their ability to build complex assemblies. To learn more about Lakeland Technology, visit http://www.lakelandtech.com.

About Nextremity Solutions, Inc.

Nextremity Solutions, Inc. is a privately held strategic commercialization organization with a focus on the extremity musculoskeletal space, offering innovative solutions and Revenue Ready® products for various extremity musculoskeletal applications for the benefit of its industry partners. The Company’s procedure-ready, sterile implant systems include uniquely precise, proprietary technology designed to achieve repeatable and superior clinical outcomes.

Source: Nextremity Solutions, Inc.

Chris J. Stewart

Chris currently serves as President and CEO of Surgio Health. Chris has close to 20 years of healthcare management experience, with an infinity to improve healthcare delivery through the development and implementation of innovative solutions that result in improved efficiencies, reduction of unnecessary financial & clinical variation, and help achieve better patient outcomes. Previously, Chris was assistant vice president and business unit leader for HPG/HCA. He has presented at numerous healthcare forums on topics that include disruptive innovation, physician engagement, shifting reimbursement models, cost per clinical episode and the future of supply chain delivery.

Related Articles

Back to top button